Command Palette

Search for a command to run...

Global Longlife Hospital and Research Ltd.
22.9(+0.00%)
1W: -10.23%

Global Longlife Hospital and Research Peer Comparison

Snapshot Summary

Global Longlife Hospital and Research Ltd. is currently underperforming against its peers in terms of growth, profitability, and valuation metrics. However, due to its low debt levels, it could be considered a deep value pick for investors looking for potential upside as the company stabilizes. Peers like Max Healthcare and Apollo Hospitals are strong performers due to robust growth and profitability metrics, making them leaders in the sector.

  • Global Longlife Hospital shows 0% revenue growth and EPS, indicating stagnation.
  • Max Healthcare leads in revenue growth YoY at 18.49% and EPS at 11.0671.
  • Apollo Hospitals has a strong ROE of 20.513% and a favorable PE of 85.15, indicating good profitability relative to its price.
  • Aster DM Healthcare is a deep value pick with a PE of 5.05 and a reasonable debt ratio, despite its declining revenues.
  • Fortis Healthcare has the highest PE at 1094.63, indicating it is overvalued given its low profitability metrics.
  • Max Healthcare Institute Ltd.: Highest revenue growth YoY (18.49%) and strong EPS growth (11.0671), with solid profitability metrics.
  • Apollo Hospitals Enterprise Ltd.: Strong ROE (20.513%) and a favorable PE ratio (85.15), indicating good value for growth.
  • Narayana Hrudayalaya Ltd.: High ROE (24.2658%) and solid growth metrics with manageable debt levels.
Stocks
CMP
Market Cap
P/E
ROCE (%)
Debt/Equity
Global Longlife Hospital and Research Ltd.₹26.40₹27.72Cr139.98--
MAXHEALTH₹1,179.65₹1,14,679.30Cr163.5816.26%0.14
APOLLOHOSP₹7,676.95₹1,10,383.03Cr85.1521.19%0.67
FORTIS₹924.85₹69,822.29Cr1094.6312.01%0.11
MEDANTA₹1,395.25₹37,474.60Cr81.2620.50%0.10
NH₹1,784.05₹36,459.02Cr84.5621.62%0.61
ASTERDM₹605.10₹30,225.53Cr5.0511.46%0.19

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.